166 related articles for article (PubMed ID: 10773878)
21. p73, a gene related to p53, is not mutated in esophageal carcinomas.
Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
[TBL] [Abstract][Full Text] [Related]
22. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
Kaghad M; Bonnet H; Yang A; Creancier L; Biscan JC; Valent A; Minty A; Chalon P; Lelias JM; Dumont X; Ferrara P; McKeon F; Caput D
Cell; 1997 Aug; 90(4):809-19. PubMed ID: 9288759
[TBL] [Abstract][Full Text] [Related]
23. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
[TBL] [Abstract][Full Text] [Related]
24. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
[TBL] [Abstract][Full Text] [Related]
25. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
Dohn M; Zhang S; Chen X
Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
[TBL] [Abstract][Full Text] [Related]
26. p73 mutations and expression in adult de novo acute myelogenous leukemia.
Stirewalt DL; Clurman B; Appelbaum FR; Willman CL; Radich JP
Leukemia; 1999 Jul; 13(7):985-90. PubMed ID: 10400412
[TBL] [Abstract][Full Text] [Related]
27. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.
Hofstetter G; Berger A; Fiegl H; Slade N; Zorić A; Holzer B; Schuster E; Mobus VJ; Reimer D; Daxenbichler G; Marth C; Zeimet AG; Concin N; Zeillinger R
Oncogene; 2010 Apr; 29(13):1997-2004. PubMed ID: 20101229
[TBL] [Abstract][Full Text] [Related]
29. p53 Family members p63 and p73 are SAM domain-containing proteins.
Thanos CD; Bowie JU
Protein Sci; 1999 Aug; 8(8):1708-10. PubMed ID: 10452616
[TBL] [Abstract][Full Text] [Related]
30. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
[TBL] [Abstract][Full Text] [Related]
31. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
[TBL] [Abstract][Full Text] [Related]
32. Activation of p73 silent allele in lung cancer.
Mai M; Yokomizo A; Qian C; Yang P; Tindall DJ; Smith DI; Liu W
Cancer Res; 1998 Jun; 58(11):2347-9. PubMed ID: 9622072
[TBL] [Abstract][Full Text] [Related]
33. Absence of mutation of the p73 gene in astrocytic neoplasms.
Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
[TBL] [Abstract][Full Text] [Related]
34. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
35. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
36. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53.
Cai YC; Yang GY; Nie Y; Wang LD; Zhao X; Song YL; Seril DN; Liao J; Xing EP; Yang CS
Carcinogenesis; 2000 Apr; 21(4):683-9. PubMed ID: 10753204
[TBL] [Abstract][Full Text] [Related]
37. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
Mihara M; Nimura Y; Ichimiya S; Sakiyama S; Kajikawa S; Adachi W; Amano J; Nakagawara A
Br J Cancer; 1999 Jan; 79(1):164-7. PubMed ID: 10408709
[TBL] [Abstract][Full Text] [Related]
38. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC
Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
[TBL] [Abstract][Full Text] [Related]
39. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma.
Takahashi H; Ichimiya S; Nimura Y; Watanabe M; Furusato M; Wakui S; Yatani R; Aizawa S; Nakagawara A
Cancer Res; 1998 May; 58(10):2076-7. PubMed ID: 9605745
[TBL] [Abstract][Full Text] [Related]
40. Mutational and expression analysis of the p73 gene in melanoma cell lines.
Tsao H; Zhang X; Majewski P; Haluska FG
Cancer Res; 1999 Jan; 59(1):172-4. PubMed ID: 9892203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
